Amaze: a double-blind, multicentre randomised controlled trial to investigate the clinical effectiveness and cost-effectiveness of adding an ablation device-based maze procedure as an adjunct to routine cardiac surgery for patients with pre-existing atrial fibrillation.

Adjunct atrial fibrillation surgery increased sinus rhythm restoration, cost about £3000 more, but did not improve quality-adjusted survival at 2 years

https://ift.tt/2jkEXbB